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Abstract
A laryngo-tracheo-esophageal cleft (LC) is a congenital malformation characterized by an abnormal, posterior, sagittal
communication between the larynx and the pharynx, possibly extending downward between the trachea and the
esophagus. The estimated annual incidence of LC is 1/10,000 to 1/20,000 live births, accounting for 0.2% to 1.5% of
congenital malformations of the larynx. These incidence rates may however be underestimated due to difficulty in
diagnosing minor forms and a high mortality rate in severe forms. A slightly higher incidence has been reported in
boys than in girls. No specific geographic distribution has been found. Depending on the severity of the malformation,
patients may present with stridor, hoarse cry, swallowing difficulties, aspirations, cough, dyspnea and cyanosis through
to early respiratory distress. Five types of laryngo-tracheo-esophageal cleft have been described based on the
downward extension of the cleft, which typically correlates with the severity of symptoms: Type 0 laryngo-tracheo-
esophageal cleft to Type 4 laryngo-tracheo-esophageal cleft. LC is often associated with other congenital abnormalities/
anomalies (16% to 68%), mainly involving the gastro-intestinal tract, which include laryngomalacia, tracheo-bronchial
dyskinesia, tracheo-bronchomalacia (mostly in types 3 and 4), and gastro-esophageal reflux disease (GERD). The
syndromes most frequently associated with an LC are Opitz/BBB syndrome, Pallister Hall syndrome, VACTERL/VATER
association, and CHARGE syndrome. Laryngeal clefts result from failure of fusion of the posterior cricoid lamina and
abnormal development of the tracheo-esophageal septum. The causes of the embryological developmental anomalies
leading to LC are not known but are thought to be multifactorial. LC appears to be mostly sporadic although some
familial cases with suspected autosomal dominant transmission have been reported. The age of diagnosis depends
mainly on the severity of the clinical symptoms and therefore on the extent of the LC. Diagnosis is made either based
on clinical manifestations or on investigations, such as endoscopy, X-ray, CT scan, performed for other conditions.
Differential diagnoses include tracheo-bronchial fistula, gastro-esophageal reflux disease and neurological swallowing
disorders, as well as laryngomalacia and laryngeal palsy. Prenatal diagnosis of LC has never been reported, although
associated anomalies may be detected on fetal ultrasonography. Once the cleft is diagnosed, it is essential to determine
its length to orient the management and treatment approach. Management involves maintenance of satisfactory
ventilation, prevention of secondary pulmonary complications as a result of repeated aspirations, and adequate feeding.
Endotracheal intubation may be required for respiratory distress in severe cases. Treatment requires endoscopic or
external surgery to close the cleft. Surgery should be performed as early as possible to avoid complications related to
aspiration and gastric reflux, except in type 0 and type 1 cases in which conservative measures must first be attempted.
The prognosis is variable depending on the severity of the LC and associated malformations. Early diagnosis and
appropriate treatment and management help to reduce mortality and morbidity.
Review
Historical delineation and disease definition
The first reported clinical case of laryngo-tracheo-oeso-
phageal cleft was made by Richter in 1792 in a newborn
presenting with recurrent aspiration [1]. The first suc-
cessful surgical reconstruction was performed in 1955
[2], and the first reliable classification system was pro-
posed in 1965 after a review of all available literature
[3]. The first large and well documented series, illustrat-
ing the guidelines of diagnostic and therapeutic strate-
gies, was proposed in 1983 [4]. Since then, numerous
manuscripts have been published regarding laryngo-tra-
cheo-oesophageal clefts and their management.
. A laryngeal-tracheo-oesophageal cleft (commonly
termed laryngeal cleft, LC) is a congenital malformation
of the posterior part of the larynx, possibly extended to
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between the laryngo-tracheal axis and the pharyngo-
oesophageal axis (Figure 1). Thus, the physiological
separation between the airway and the digestive tract is
lost, leading to chronic cough, aspiration, respiratory
distress, pneumonia.... The severity of a LC is directly
correlated to the downward extension of the cleft. This
disease is registered in both Orphanet (ORPHA2004)
and OMIM (#215800) databases [5].
Recent advances in knowledge, diagnosis and, above
all, the treatment of LC, have led to significant improve-
ments in survival and quality of life of these patients.
Classifications
Over the past 50 years, many classifications of LC have
been proposed, all based on the downward extension of
the cleft: Petterson (1955), Armitage (1984), Evans
(1985), Benjamin (1989), Meyer (1990), DuBois (1990),
and Sandu (2006) [6]. All have a threefold interest:
- Descriptive; allowing the comparison of a series of
patients in the literature;
- Therapeutic; influencing the choice of a recon-
structive technique and surgical approach
- Prognostic; as success and survival rates are highly
correlated to the extension of the LC.
To date, the Benjamin and Inglis classification [7],
modified by Sandu in 2006 [8], are the most frequently
used (Figure 2). Indeed, they differentiate partial and
total cleft of the cricoid cartilage, as well as cervical and
tracheo-thoracic cleft. Those elements are essential in
the choice of a therapeutic strategy.
Type 0: submucosal cleft
Type I: supraglottic, interarytenoid cleft, above the
vocal fold level
Type II: cleft extending below the vocal folds into the
cricoid cartilage
Type III a: cleft extending through the cricoid carti-
lage but not into the trachea
Type III b: cleft extending through the cricoid carti-
lage and into the cervical trachea
Type IV: cleft extending into the thoracic trachea,
potentially down to the carina
Submucosal LC was initially described by Tucker in
1987 [9] as a posterior, sagital, submucosal, cartilage
defect with intact soft tissues (mucosa and interaryte-
noid muscle). It is clinically relevant, since it has been
described with other anomalies of the cricoid cartilage,
including congenital subglottic stenosis [10].
Epidemiology
LC is a rare, congenital, anomaly. It is widely accepted
that its incidence is probably underestimated. Indeed, 1)
minor LC (type 0 or type 1) may either be asymptomatic
or show only mild symptoms; 2) the endoscopic diagnosis
is difficult and several reports exist a missed malforma-
tion despite a well-conducted endoscopic assessment; 3)
high-grade LC (type 4) have a high mortality rate, often
leading to the patient’s death before diagnosis can be
made; 4) the endoscopic assessment may not be a priority
in cases with numerous associated malformations.
As such, the estimated incidence of LC is 1 in 10,000
to 20,000 living births [6,11,12], representing about 0.2%
to 1.5% of the congenital malformations of the larynx
[10,13-17].
From 1990 to 1995, of the 2,338 endoscopies carried
out in a specialized paediatric department, only 7 cases
of laryngeal cleft were identified (0.3%) [10]. In 1971, a
review of 433 cases of laryngeal malformations identified
2 cases of LC (0.5%) [17]. An initial study conducted
Figure 1 Type III LC, endoscopic view.* :a r y t e n o i d s ;X :t r a c h e a l
lumen. Palpation of the cleft.
Figure 2 Benjamin and Inglis’ original classification [7].
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uated for chronic cough or aspiration, 20 cases of type I
LC (7.6%) [18]. This incidence, higher than that pre-
viously mentioned, appears to be more in line with rea-
lity due to: 1) a better understanding of the disease and
its diagnosis and 2) a pre-selection of patients.
LC has a slightly higher incidence in boys than in
girls, with a ratio of 1.2 [19] to 1.8 [20]. Even if data on
this subject is scarce, no evidence appears to exist relat-
ing to an occurrence of a specific racial predominance
[20]. Cases of LC appear to be mostly sporadic. How-
ever, reports exist of families with multiple children hav-
i n gac l e f t .I nt h e s ep a t i e n t s ,t h ep o s s i b i l i t yo fa n
autosomal dominant transmission has been suggested
[21]. Alcohol and/or drug abuse during pregnancy, mul-
tiple miscarriages, hydramnios and prematurity are fre-
q u e n t l yr e p o r t e d ,b u tn o n eh a v eb e e np r o v e nt ob ea
specific risk factor [1,10].
Etiopathology: embryology and animal model
In the classic embryological description of the respira-
tory system, the larynx develops from two tissues evol-
ving in parallel: the endoderm coming from the foregut
and the mesenchymal elements from the 4
th and 6
th
branchial arches [22]. The division of the foregut is the
result of the fusion of lateral ridges appearing in the lat-
eral walls of the foregut. This process starts caudally
and ends cranially to the region of the larynx, thus
forming a septum that divides the foregut into a ventral
portion - the laryngo-tracheal tube - and a dorsal por-
tion - the oesophagus.
Recently, researchers studying the embryology of the
foregut of chick embryos, failed to identify subtle lat-
eral ridges and suggested that the development of
both the trachea and the oesophagus could result
from a size reduction of the foregut, caused by a sys-
tem of folds that get close but do not merge [22].
This system of folds could appear in the foregut and
involve the tracheo oesophageal space in both the cra-
nial and caudal areas: the caudal with a cranial devel-
opment and the two cranial folds with a caudal
evolution. Moreover, the respiratory diverticulum has
also been described; the latter developing from the
ventral area of the foregut and continuing to elongate
downward to form the trachea [23]. The portion of
the mesenchyme, known as the tracheo-oesophageal
septum, located between the digestive and respiratory
tracts, is the result of the separation of the two tracts.
Apoptotic mechanisms are also involved in the growth
and evolution of tissues: apoptotic epithelial cells can
be found at the tracheo-oesophageal separation site in
the ventral part of the foregut, where cellular activity
is intense, whereas the dorsal part remains inactive
[24].
Several models have been proposed to explain tra-
cheo-oesophageal anomalies, including LC [25]:
- Intra-embryonic pressure: an intense curvature of the
cervical region, during the heart’s development, could
cause a strain and a displacement of the oesophagus,
resulting in growth anomalies.
- Epithelial occlusion: the oesophagus has a solid stage
of development, and eventually re-canalizes. A failure of
this latter process could result in malformations.
- Vascular occlusion: the persistence of an abnormal
vessel could lead to vascular insufficiency in the foregut,
resulting in growth anomalies.
- Differential cell growth: abnormal cell development in
either the ventral or dorsal part of the developing tracheo-
oesophagus could result in oesophageal or tracheal defects.
It has been suggested that a premature arrest in devel-
opment of the tracheo-oesophageal septum, and the lack
of fusion of the two lateral parts of the developing cri-
coid cartilage, could be responsible for LC [3]. This
model, however, does not explain the mechanism of
associated malformation, such as laryngeal atresia and
tracheo-oesophageal fistula.
An animal model of laryngo-tracheal malformations
has been described in rat embryos exposed to doxorubi-
cin (Adriamycin
®) [25-28]. After exposure, these
embryos display major tracheo-oesophageal anomalies,
similar to those described in the VACTERL association
(oesophageal atresia and tracheo-oesophageal fistula).
However, LC has not yet been observed in this model
under experimental conditions.
Clinical description
Clinical symptoms
The intensity of clinical symptoms of laryngeal clefts
typically correlates with the type of cleft itself [10,19].
Most frequent symptoms are summarized in Table 1.
Type 0 clefts may display mild to no obvious symp-
toms (occasional aspiration) when clinically isolated, but
association with other airway malformations or syn-
dromes is possible. They are often discovered during an
endoscopy or an external procedure initiated for other
reasons, and their diagnosis is especially difficult if the
surgeon is not aware of their clinical appearance
[9,29,30].
Table 1 Most frequent clinical symptoms [1]
Swallowing disorders
(50%)
Aspiration and cyanosis during feeding (53 to
80%)
Chronic cough (27 to 35%)
Pharynx and larynx
(43%)
Stridor (10 to 60%)
Toneless or weak cry (16%)
Pharyngeal hypersecretions (10 to 23%)
Respiratory (37%) Recurrent pneumonia (16 to 54%)
Respiratory distress at birth
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symptoms, including stridor, a toneless or hoarse cry,
and swallowing disorders. Aspiration, cough, dyspnoea
and cyanosis during feeding are possible but not routine.
T h ei m p a c to nt h ep u l m o n a r yt r a c ti su s u a l l yn o n et o
mild.
Type II and III clefts usually display more swallowing
disorders (aspiration mostly) and pulmonary tract
infections.
Type IV has a poor prognosis, due to the early
respiratory distress they cause, and to the difficulty of
maintaining correct mechanical ventilation [20,31-33].
However, some cases of large LCs with a surprisingly
little symptomatology have been documented. It is sup-
posed that the excess of oesophageal mucosa herniating
into the cleft in the LC provides, in these cases, some
degree of protection against aspiration. However, this
mucosal hernia has also been proposed as the cause of
stridor and airway obstruction.
The age at which a diagnosis is made depends mostly
on the severity of the clinical symptoms, and therefore
on the extent of the LC itself. Moreover, the experience
of the medical team managing the LC may also influence
the age at which a diagnosis is made, especially when the
associated malformations are mild or none [14,16,34]. In
the literature, the age at diagnosis is very variable. Thus,
in one series, type 0 LC were diagnosed at an average age
of 6 months, type I before the age of 6 months and type
II before the age of 2 months [19]. In another series, [29],
the average age at diagnosis, regardless of the type of
cleft, was 15 days to 12 years of age.
Thus, every swallowing disorder (cough during feeding,
aspiration and/or cyanosis) should lead to an endoscopic
examination of the child’s airways to assess for a LC.
Associated syndromes
LC is often associated with other congenital abnormal-
ities (16% to 68%), mostly malformations of the digestive
tract [4,29]. A full examination of both digestive and
respiratory tracts is therefore mandatory during the
assessment of a LC.
These associated malformations may be syndromic or
appear isolated. Four syndromes are among the most
frequently associated with a LC:
- The Opitz G/BBB syndrome (Orpha2745/OMIM
#145410), characterized by laryngeal malformations
(including LCs) which are associated with craniofa-
cial anomalies (pinna malformations, cleft lip and
palate, hypertelorism), genitourinary anomalies
(hypospadias), and other malformations of the ven-
tral midline. Two forms exist: one with an autosomal
dominant inheritance and the other with an X-linked
inheritance.
- The 22q11 monosomy (CATCH 22, 22q11 micro-
deletion, DiGeorge syndrome...) (Orpha567/OMIM
#192430 and #188400). This syndrome may include
numerous malformations especially hypoplasic thy-
mus and parathyroid glands, cardiopathy, velophar-
yngeal insufficiency with or without cleft palate, and
sometimes LC. The clinical course mainly depends
on the malformations involved. Its overall incidence
is estimated at 1/5000 births, but is much lower
when associated with LC.
- The Pallister Hall syndrome (Orpha672/OMIM
#146510) is characterized by the association of laryn-
geal (LC), gastrointestinal, cardiopulmonary, limb
(polydactyl and syndactyl) and neurological malfor-
mations (congenital hypothalamic hamartoblastoma
with hypopituitarism). Its inheritance is autosomal
dominant.
- The VACTERL association (Orpha887/OMIM
#192350). Its aetiology is still unknown in man. The
acronym stands for Vertebral, Anal, Cardiac, Tra-
cheo-oesophageal (including LC), Ear (middle and
inner), Renal, and Limb malformations.
- The CHARGE syndrome (Orpha138/OMIM
#214800) results in the main, from a CHD7 gene muta-
tion. The acronym stands for Coloboma, Heart malfor-
mations, choanal Atresia (uni- or bilateral), growth and
mental Retardation, Genitourinary malformations, and
Ear malformations (external, middle, and inner ear).
Several other malformations may also be associated,
some of them constant (e.g. olfactory bulb hypoplasia
and semi-circular canal anomalies). An LC may also be
associated with many other cranial malformations (cleft
lip and palate, laryngomalacia, laryngeal webs...).
Furthermore, several other associated malformations
are possible as shown in Table 2. It is likely that most
of these malformations are in fact linked to not-yet
identified syndromes. However, a purely isolated LC is
also possible.
Diagnostic methodology
Endoscopic examination
Several different diagnoses are possible, and among
them tracheobronchial fistulas, laryngomalacia, laryn-
geal palsy, gastro-oesophageal reflux (GERD), neuro-
logical swallowing disorders... Most of these diagnoses
can be ruled out during the endoscopic examination.
The endoscopic assessment is essential to LC diagnosis.
It must be conducted with special care and attention,
because it is possible to miss a low-grade malformation if
the examiner is not especially aware of it [15].
Such endoscopic examination must be conducted in
the operating room and includes:
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anaesthesia, looking for laryngomalacia, direct
aspiration, and assessing laryngeal mobility and sen-
sitivity. A LC may be suspected at this time, but
usually cannot be diagnosed with certainty [29].
- A full examination of the airways and the oesopha-
gus with rigid telescopes, under general anaesthesia
with spontaneous breathing, in order not to miss a
tracheo-bronchial dyskinesia, or a tracheo-bronchial
laryngomalacia (50 to 66%). The entire respiratory
tract must be assessed because tracheo-bronchial fis-
tulas are associated in 10 to 60% of the cases [34,35].
The larynx must then be examined with microlaryn-
goscopy during a laryngeal suspension, using high
magnification either witham i c r o s c o p eo rv i d e o
monitored telescope [36]. A preliminary topical
application of 1% lidocaine may help before cleft pal-
pation. The posterior glottis must be carefully
inspected and palpated, looking for a sagittal cleft
between the digestive and the respiratory tracts (Fig-
ure 3). A LC may be inadvertently overlooked
because of the redundant mucosa between the oeso-
phagus and trachea, prolapsing into the cleft. Several
probes have been designed and proposed for cleft
palpation [16]. Once the diagnosis is made, it is fun-
damental to assess the length of the cleft [11].
The endoscopic examination may also show associated
anomalies such as:
- laryngomalacia (5 to 33%) [11,35,37]
- tracheo-bronchial dyskinesia [11]
- tracheo-bronchomalacia, mostly in type III and IV
clefts [12,38]
- tracheo-oesophageal fistula [20]
- GERD [11,16,18].
Radiological assessment
Routine chest X-rays are usually not conclusive and may
only provide signs of parenchyma anomalies secondary
to aspiration. It has been reported on CT-scans, in some
patients, that an abnormal communication and a lack of
soft tissue exists between the trachea and the oesopha-
gus can occasionally be found [39], as well as an abnor-
mal anterior or intra-tracheal position of a nasogastric
tube [6,10]. However, neither standard X-ray examina-
tions nor CT-scans are commonly used to diagnose an
LC. Similarly, MRI scans are also not commonly used in
the diagnosis of LCs, but they are usually needed to
assess the associated malformations.
A barium swallow study, most often used to locate a
tracheo-oesophageal fistula, will immediately show the
flow of the barium into the trachea thereby possibly
leading to a false diagnosis of a tracheo oesophageal fis-
tula due to a lack of knowledge of laryngeal clefts by
radiologists [15].
Diagnostic methods and complemenraty investigations
Once a LC has been diagnosed, a systematic course of
action is critical. This includes, in addition to the endo-
scopic assessment, at least [1]:
- A genetic counselling with family history, full clini-
cal examination and systematic karyotype. According
to the clinical findings, specific genetic gene anoma-
lies will be looked for by cytogenetic techniques (e.g.
M I D - 1f o rO p i t zG ,T B X 1f o r2 2 q 1 1m i c r o d e l e t i o n ,
GLI3 for Pallister Hall, CHD7 and SEMA3E for
Table 2 Frequent non-syndromic associated
malformations [1]
Localisation Malformation
Digestive tract
(16 to 67%)
[19,31,32,45,46]
Esophageal atresia (20 to 37%)
Tracheo-esophageal fistula (10 to 20%)
Anal atresia (21%)
Abnormal intestinal rotation (13%)
Meconium ileus (8%)
Microgastria
Exomphalos
Genitourinary tract
(14 to 44%)
[39]
Hypospadias (7 to 13%)
Kidney malformation (4%)
Inguinal hernia, cryptorchidism
Cardiovascular system
(16 to 33%)
Coarctation of the aorta, transposition of the
great vessels
Ductus arteriosus
Craniofacial
(5 to 15%)
Cleft lip and palate (5%)
Choanal atresia
Micrognathia, glossoptosis
Hypertelorism, dysmorphia
Anomaly of the external ear
Tracheo-broncho-
pulmonary
(2 to 9%)
[46]
Short trachea
Bronchial, tracheal stenosis
Abnormal lung segmentation, hypoplasia
Figure 3 Endoscopic view; palpation of the posterior cleft.
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ing with typical clinical features, no specific genetic
anomalies can be found.
- Cardiac and renal ultrasonographies
- Spinal (cervical) x-rays
- Hearing screening
In the frequent case of associated malformations
requiring surgery, the choice of the surgical sequence
will be made according to the child’sc o n d i t i o na n d
respiratory status.
Treatment
Medical management
Medical management aims to: 1- maintain satisfactory
ventilation in children presenting an obstructive form of
LC (mostly by prolapsing mucosa), 2- prevent secondary
pulmonary complications as a result of repeated aspira-
tion and 3- ensure adequate feeding of the child.
In cases of respiratory distress (possibly neonatal), an
endotracheal intubation may be required. This proce-
dure carries for LCs (except for grades 0 and I), a high
risk of tube misplacement and should be undertaken
under endoscopic control. For grade 4 LCs, the stability
of the tube in the airway and the quality of mechanical
ventilation may be difficult to maintain. Placing the tip
o ft h et u b ev e r yc l o s et ot h ec a r i n ai sh e l p f u l .I fat r a -
cheotomy is decided upon, the placement of the cannula
also requires an endoscopic control. In extreme type IV
LCs, trachea and oesophagus are merged in one single
tract and ventilation is extremely hard to maintain; the
prognosis is therefore very guarded [6,15,19,39,40].
Noninvasive positive pressure ventilation (continuous
or bi-level positive air pressure) is not recommended in
children with a non-operated LC, because of: 1- the
mobile, mucosal, obstructive component of the airway
which can be displaced by the positive pressure, thus
worsening the obstruction and 2- the increased risk of
secondary pulmonary infection resulting from the
aspiration, increased by the air flow. However, in a case
of relapse of obstructive symptoms after surgery, this
non-invasive ventilation technique may be helpful.
In a recently operated upon child, an endotracheal
intubation (e.g. for a secondary respiratory distress)
should be approached with extra care, for it can com-
promise the surgical reconstruction before healing is
complete.
Children with a mildly symptomatic type I LC may be
fed with thickened food, generally with good success.
GERD treatment and postprandial upright position are
also helpful [34,41,42]. Patients with a symptomatic type I
or II LC will benefit from an anti-reflux treatment and
nasogastric tube feeding [29]. In some cases of significant
type III or type IV clefts, the risk of aspiration is so high
that parenteral nutrition may temporarily be necessary
[39,43]. High grade LCs often require a mid- to long- term
gastrostomy (often with fundoplication) [11,35,37]. Gastric
division with a proximal drainage tube and distal gastro-
stomy have also been proposed for type IV LCs [36,44-46].
Surgical management
Two surgical standards exist for LCs: the external and
endoscopic approaches. The classical, systematic, exter-
nal approach has been partially replaced by endoscopic
procedures during the last decade. However, high grade
LC or cases of endoscopic failures still require a classical
approach.
￿ External approach
Approaching the cleft
Depending on the type of LC and the experience of the
surgical team, different cervical approaches are possible:
lateral with lateral or posterior pharyngotomy, and ante-
rior laryngotracheal.
The lateral approach with lateral pharyngotomy has
been recommended for low grade LCs with less than 2
cm of cervical trachea involved [6]. Its drawback is the
risk of recurrent and pharyngeal injuries to the nerves
The lateral approach with posterior pharyngotomy is
seldom used [15]. The risk of nerve injury is lower, but
the control of the upper part of the cleft in the interary-
tenoid region can be difficult [19].
The anterior laryngotracheal approach is the most
widely used open technique. It provides an excellent expo-
sure of the cleft with minimal neck dissection, and pre-
sents no risk of nerve damage (Figure 4). Once the cleft is
closed, it is fundamental to ensure the postoperative stabi-
lity of the larynx. Despite early concerns, it has been
shown that the larynx has a normal growth pattern after
such a procedure [47]. In brief, the skin incision is
Figure 4 Type III LC, per-operative anterior view (external
approach); *: arytenoids; o: esophagus. The posterior wall of the
pharynx is visible thru the cleft.
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sectioning off the thyroid isthmus, the larynx is opened
vertically, in accordance with the width of the cleft. The
airway can be maintained per-operatively by either a tra-
cheotomy [19,48,49] or an endotracheal tube placed in the
tracheal incision and replaced by a standard intubation at
the end of the procedure [1,34,47]. Our preference is for
the latter technique, which avoids: 1- an additional tra-
cheal trauma, 2- a potential tracheal ischemia by compres-
sion, and 3- the morbidity of a paediatric tracheotomy.
Two types of thoracic approaches have been
described: anterior (with a sternotomy) and lateral; both
combined with a cervical incision [20,44,46,50-53].
Combined cervical and thoracic approaches are only
indicated in type IV clefts, and may also require cardio-
pulmonary bypass or extracorporeal membrane oxyge-
nation [51-53].
Closing the cleft
Several closure techniques have been described: 1- a
multi-layer closure after excision of excess mucosa
[34,54] and 2- the use of asymmetric flaps with non-
overlapping suture lines [39,48]. The first concern
with both those reconstructive techniques is the risk
of ischemic damage on the recently created suture
line by the endotracheal tube, a tracheotomy or the
nasogastric tube. Because of this risk, the authors
b e l i e v et h a tt h eu s eo fat e mporary endotracheal tube
is preferable to a tracheotomy [34,51]; similarly, a gas-
trostomy is preferable to a long-term nasogastric feed-
ing tube.
In order to lower the risk of secondary opening, inter-
position grafts can be used: tibial periosteum or auricu-
lar cartilage [34], sternocleidomastoid muscle flap [20],
fascia temporalis [55], costal cartilage [56], pleural flap
[43,50,57], or even pericardium [51]. The authors prefer
tibial periosteum as primary grafting material because it
is easy to harvest and manipulate, and due to the satisfy-
ing results experienced by the authors in this indication
[29,58].
Even after an uneventful procedure, and irrespective of
the technique used, the risk of relapse of the LC (sec-
ondary re-opening of the cleft) requiring a revision is
high: currently documented at 11% to 50%
[29,43,46,58-61]. Thus, multiple procedures are common
in LC management.
Tracheomalacia is a frequent issue in the post-opera-
tive management of type III and type IV clefts, and may
require the use of a stent by tracheotomy [45,46,51],
excision of the malacic segment [12], aortopexy [12,46],
or positive pressure ventilation [34,37,38,45,62].
The latter is a non-invasive technique, which generally
allows a satisfactory control of the obstructive symptoms
without additional surgical procedures, and, in the
authors opinion, should be the intended first.
￿ Endoscopic approach Since its early beginning in the
1980’s, numerous publications have described the endo-
scopic technique for the closure of type I and type II LC
[8,29,41,55,58,60,63,64]. Recently, successful cases of
endoscopic closure of type III clefts have also been
reported [58,60].
Endoscopic surgery has many advantages: no skin inci-
sion, no laryngeal opening, and the possibility of repeat-
ing the surgery easily without great additional morbidity.
It is performed under general anaesthesia with sponta-
neous breathing and thus requires an experienced team
of paediatric otolaryngologist surgeons and anaesthesiol-
ogists. Type I clefts have been closed endoscopically
with an endotracheal tube in the airway [6], but sponta-
neous breathing allows an optimum exposure of the
operating field itself.
The cleft closure is performed under suspension laryn-
goscopy, using a microscope and specific cold instru-
ments: an endoscopic needle driver and a knot pusher
[29,58,60]. Most authors also prepare the cleft before
closure by denuding the mucosal margins using a CO2
or Thulium (Revolix
©, LISA Laser, Katlenburg-Lindau,
Germany) LASER. The dissection of the cleft, necessary
prior to the two-layer non-absorbable suture (e.g. Pro-
lene
© 6/0 dual 9.3 mm needle) requires regular micro-
laryngoscopy instruments (Collin ORL, Bagneux,
France) and mostly experience and patience from the
surgeon and his assistant. The sutures are ideally placed
on the pharyngeal side of the posterior wall of the lar-
ynx, in order to avoid irritation of the larynx and fall
into the airway. In neonates or small infants, especially
with a respiratory condition, the realization of a 2 layer
suture may be difficult to achieve. In these cases, one
must be careful to perform at least a 1-layer suture clo-
sure with 3 or more sutures. The sutures have to be
tight enough to limit secondary opening of the cleft, but
must not narrow the laryngeal lumen or be an obstacle
to arytenoid movement.
The patients usually spend the first night in intensive
care because of the risk of secondary oedema leading to
respiratory distress, and can be fed after 7 to 14 days.
Some authors prefer a re-intubation for a few days [18],
and others non-invasive ventilation [8].
Endoscopic LC surgery has satisfactory success rates:
80% to 100% [1,8,11,18,29,41,58,60].
Endoscopic positioning of an interposition graft is
technically very difficult, not to say impossible. However,
authors have experienced the use of complementary
materials, with varying success rates: collagen [65], Gel-
foam
® [66], and more recently bioplastic [64], in order
to improve long-term results, Bioplastic beingless
absorbable than the previous materials. These proce-
dures with injectable materials have been mostly pro-
posed in type I clefts and remain used by few teams.
Leboulanger and Garabédian Orphanet Journal of Rare Diseases 2011, 6:81
http://www.ojrd.com/content/6/1/81
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procedures without injectable materials, long-term
results involving more patients are required before these
techniques can be recommended.
The low morbidity and the favourable results of the
endoscopic approach have made it the technique of
choice for type I and II LCs. Moreover, several cases of
type III LC successfully treated by endoscopic means
have recently been reported [1,29,58,60]. However, it is
likely that despite the advances in surgery and anaesthe-
siology, some type III and all the type IV will never ben-
efit from the endoscopic approach.
￿ Therapeutic timing and strategy The prognosis of
LC is closely linked to the grade of the cleft, the asso-
ciated conditions, and the pulmonary status of the
patient. In all cases, surgery should be performed as
soon as possible to avoid complications related to the
aspiration and gastric reflux [11,29,41,51]. However, the
degree of severity and thus the need for rapid manage-
ment is very different between the different forms of the
disease.
Submucosal clefts can be especially problematic. In
the rare cases where they are the only malformation and
have no clinical impact, a watchful surveillance can be
proposed. However, the presence of a submucosal cleft
has been described as a contributing factor to the failure
of an airway reconstruction procedure. Thus, this type
of cleft should be taken care of concomitantly with to
the other malformation, usually with a posterior graft
via an external approach [30].
A toddler with a grade 1 LC presenting with mild
symptoms and occasional aspiration - without associated
conditions - will be managed very differently to a new-
born with a grade 4 LC, (massive saliva aspiration,
unstable endotracheal intubation, associated great vessel
malformations) and whose survival will be compromised
during the first hours of life.
Prognosis
During the recent decades, advances in both medical
care and surgical techniques have notably improved the
prognosis of LCs. The overall mortality rate in a series
of patients in 1983 was 46% [4] and has dropped to 6%
- 25% in most recent reports [54,55,58,60]. This
improvement in survival can be explained not only by
the advances in treatment and management, but also by
an earlier diagnosis. Indeed, the sooner a diagnosis is
made, the greater the reduction in morbidity and
mortality.
However, comparing different series is difficult
because of: 1- the low incidence of pathology, 2- the
inhomogeneity of the groups of patients in these series,
3- the important differences in clinical presentation and
prognosis of the different grades of LC, and 4- the
impact of associated malformations. The mortality rate
for type IV LC only, for example, was estimated at 93%
in 1985 [4] and is now below 50% [32,37,54].
Conclusion
LCs are rare malformations of the larynx, whose prog-
nosis is highly dependant on the extension of the cleft
and other associated malformations. The origin and
development of this malformation is as yet not perfectly
understood. Isolated LCs are unusual but possible. The
management of low-grade LCs (I, II, and some III) has
recently been drastically improved by the development
of endoscopic surgical techniques, leading to significant
improvements in survival and quality of life of patients.
However, high-grade LCs or recurrences will still neces-
sitate an open approach procedure.
List of abbreviations
LC: laryngo-tracheo-oesophageal cleft.
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